Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.
[en] We have previously shown (K. Kas et al, Nat. Genet., 15: 170-174, 1997) that the developmentally regulated zinc finger gene pleomorphic adenoma gene 1 (PLAG1) is the target gene in 8q12 in pleomorphic adenomas of the salivary glands with t(3;8)(p21;q12) translocations. The t(3;8) results in promoter swapping between PLAG1 and the constitutively expressed gene for beta-catenin (CTNNB1), leading to activation of PLAG1 expression and reduced expression of CTNNB1. Here we have studied the expression of PLAG1 by Northern blot analysis in 47 primary benign and malignant human tumors with or without cytogenetic abnormalities of 8q12. Overexpression of PLAG1 was found in 23 tumors (49%). Thirteen of 17 pleomorphic adenomas with a normal karyotype and 5 of 10 with 12q13-15 abnormalities overexpressed PLAG1, which demonstrates that PLAG1 activation is a frequent event in adenomas irrespective of karyotype. In contrast, PLAG1 was overexpressed in only 2 of 11 malignant salivary gland tumors analyzed, which suggests that, at least in salivary gland tumors, PLAG1 activation preferentially occurs in benign tumors. PLAG1 over-expression was also found in three of nine mesenchymal tumors, i.e., in two uterine leiomyomas and one leiomyosarcoma. RNase protection, rapid amplification of 5'-cDNA ends (5'-RACE), and reverse transcription-PCR analyses of five adenomas with a normal karyotype revealed fusion transcripts in three tumors. Nucleotide sequence analysis of these showed that they contained fusions between PLAG1 and CTNNB1 (one case) or PLAG1 and a novel fusion partner gene, i.e., the gene encoding the transcription elongation factor SII (two cases). The fusions occurred in the 5' noncoding region of PLAG1, leading to exchange of regulatory control elements and, as a consequence, activation of PLAG1 gene expression. Because all of the cases had grossly normal karyotypes, the rearrangements must result from cryptic rearrangements. The results suggest that in addition to chromosomal translocations and cryptic rearrangements, PLAG1 may also be activated by mutations or indirect mechanisms. Our findings establish a conserved mechanism of PLAG1 activation in salivary gland tumors with and without 8q12 aberrations, which indicates that such activation is a frequent event in these tumors.
Disciplines :
Genetics & genetic processes
Author, co-author :
Astrom, A. K.
Voz, Marianne ; Université de Liège - ULiège > Département des sciences de la vie > GIGA-R : Biologie et génétique moléculaire
Kas, K.
Roijer, E.
Wedell, B.
Mandahl, N.
Van de Ven, W.
Mark, J.
Stenman, G.
Language :
English
Title :
Conserved mechanism of PLAG1 activation in salivary gland tumors with and without chromosome 8q12 abnormalities: identification of SII as a new fusion partner gene.
Publication date :
1999
Journal title :
Cancer Research
ISSN :
0008-5472
eISSN :
1538-7445
Publisher :
American Association for Cancer Research, Inc. (AACR), Baltimore, United States - Maryland
Kas, K., Voz, M.L., Röijer, E., Åström, A.-K., Meyen, E., Stenman, G., Van De Ven, W.J., Promoter swapping between the genes for a novel zinc finger protein and β-catenin in pleiomorphic adenomas with t(3
8)(p21
q12) translocations (1997) Nat. Genet., 15, pp. 170-174
Kas, K., Röijer, E., Voz, M., Meyen, E., Stenman, G., Van De Ven, W.J., A 2-Mb YAC contig and physical map covering the chromosome 8q12 breakpoint cluster region in pleomorphic adenomas of the salivary glands (1997) Genomics, 43, pp. 349-358
Kas, K., Voz, M.L., Hensen, K., Meyen, E., Van De Ven, W.J.M., Transcriptional activation capacity of the novel PLAG family of zinc finger proteins (1998) J. Biol. Chem., 273, pp. 23026-23032
Peifer, M., β-catenin as oncogene: The smoking gun (1997) Science (Washington DC), 275, pp. 1752-1753
Willert, K., Nusse, R., β-catenin: A key mediator of Wnt signaling (1998) Curr. Opin. Genet. Dev., 8, pp. 95-102
Voz, M.L., Åström, A.-K., Kas, K., Mark, J., Stenman, G., Van De Ven, W.J., The recurrent translocation t(5
8)(p13
q12) in pleomorphic adenomas results in upregulation of PLAG1 gene expression under control of the LIFR promoter (1998) Oncogene, 16, pp. 1409-1416
Gearing, D.P., Thut, C.J., VandeBos, T., Gimpel, S.D., Delaney, P.B., King, J., Price, V., Beckmann, M.P., Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130 (1991) EMBO J., 10, pp. 2839-2848
Sandros, J., Stenman, G., Mark, J., Cytogenetic and molecular observations in human and experimental salivary gland tumors (1990) Cancer Genet. Cytogenet., 44, pp. 153-167
Bullerdiek, J., Wobst, G., Meyer-Bolte, K., Chilla, R., Haubrich, J., Thode, B., Bartnitzke, S., Cytogenetic subtyping of 220 salivary gland pleomorphic adenomas: Correlation to occurrence, histological subtype, and in vitro cellular behavior (1993) Cancer Genet. Cytogenet., 65, pp. 27-31
Mark, J., Dahlenfors, R., Wedell, B., Impact of the in vitro technique used on the cytogenetic patterns in pleomorphic adenomas (1997) Cancer Genet. Cytogenet., 95, pp. 9-15
Schoenmakers, E.F., Wanschura, S., Mols, R., Bullerdiek, J., Van Den Berghe, H., Van De Ven, W.J., Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours (1995) Nat. Genet., 10, pp. 436-444
Geurts, J.M., Schoenmakers, E.F., Röijer, E., Stenman, G., Van De Ven, W.J., Expression of reciprocal hybrid transcripts of HMGIC and FHIT in a pleomorphic adenoma of the parotid gland (1997) Cancer Res, 57, pp. 13-17
Geurts, J.M., Schoenmakers, E.F., Röijer, E., Åström, A.-K., Stenman, G., Van De Ven, W.J., Identification of NFIB as recurrent translocation partner gene of HMGIC in pleomorphic adenomas (1998) Oncogene, 16, pp. 865-872
Ashar, H.R., Fejzo, M.S., Tkachenko, A., Zhou, X., Fletcher, J.A., Weremowicz, S., Morton, C.C., Chada, K., Disruption of the architectural factor HMGI-C. DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains (1995) Cell, 82, pp. 57-65
Petit, M.M.R., Mols, R., Schoenmakers, E.F., Mandahl, N., Van De Ven, W.J., LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family (1996) Genomics, 36, pp. 118-129
Rogalla, P., Kazmierczak, B., Meyer-Bolle, K., Tran, K.H., Bullerdick, J., The t(3
12)(q27
q14-q15) with underlying HMGIC-LPP fusion is not determining an adipocytic phenotype (1998) Genes Chromosomes Cancer, 22, pp. 100-104
Nordkvist, A., Mark, J., Gustafsson, H., Bang, G., Stenman, G., Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands (1994) Genes Chromosomes Cancer, 10, pp. 115-121
Sambrook, J., Fritsch, E.F., Maniatis, T., (1989) Molecular Cloning: A Laboratory Manual, 2nd Ed., pp. 11-1888. , Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
Baier, G., Telford, D., Gulbins, E., Yamada, N., Kawakami, T., Allman, A., Improved specificity of RT-PCR amplifications using nested cDNA primers (1993) Nucleic-Acids Res., 21, pp. 1329-1330
DiMarco, S.P., Glover, T.W., Miller, D.E., Reines, D., Warren, S.T., Transcription elongation factor SII (TCEA) maps to human chromosome 3p22->p21.3 (1996) Genomics, 36, pp. 185-188
Park, H., Back, K., Jeon, C., Agarwal, K., Yoo, O., Characterization of the gene-encoding the human transcriptional elongation factor TFIIS (1994) Gene, 139, pp. 263-267
Reines, D., Conaway, J.W., Conaway, R.C., The RNA polymerase II general elongation factors (1996) Trends Biochem. Sci., 21, pp. 351-355
Kanai, A., Kuzuhara, T., Sekimizu, K., Natori, S., Heterogeneity and tissue-specific expression of eukaryotic transcription factor S-II-related protein mRNA (1991) J. Biochem. (Tokyo), 109, pp. 674-677
Plant, K.E., Hair, A., Morgan, G.T., Genes encoding isoforms of transcription elongation factor TFIIS in Xenopus and the use of multiple unusual RNA processing signals (1996) Nucleic Acids Res., 24, pp. 3514-3521
Weaver, Z.A., Kane, C.M., Genomic characterization of a testis-specific TFIIS (TCEA2) gene (1997) Genomics, 46, pp. 516-519
Akasaka, T., Miura, I., Takahashi, N., Akasaka, H., Yonetani, N., Ohno, H., Fukuhara, S., Okuma, M., A recurring translocation, t(3
6)(q27
p21), in non-Hodgkin's lymphoma results in replacement of the 5′ regulatory region of BCL6 with a novel H4 histone gene (1997) Cancer Res., 57, pp. 7-12
Migliazza, A., Martinotti, S., Chen, W., Fusco, C., Ye, B.H., Knowles, D.M., Offit, K., Dalla-Favera, R., Frequent somatic hypermutation of the 5′ noncoding region of the BCL6 gene in B-cell lymphoma (1995) Proc. Natl. Acad. Sci. USA, 92, pp. 12520-12524
Bernardin, F., Collyn-D'Hooghe, M., Quief, S., Bastard, C., Leprince, D., Kerckaert, J.P., Small deletions occur in highly conserved regions of the LAZ3/BCL6 major translocation cluster in one case of non-Hodgkin's lymphoma without 3q27 translocation (1997) Oncogene, 14, pp. 849-855
Nakamura, Y., Miki, T., Kawamata, N., Hirosawa, S., Saito, K., Enokihara, H., Furosawa, S., Shishido, H., Biallelic DNA rearrangements and deletions within the BCL-6 gene in B-cell non-Hodgkin's lymphoma (1995) Br J. Haematol., 90, pp. 404-408
Gnepp, D.R., Wenig, B.M., Malignant mixed tumors (1991) Surgical Pathology of the Salivary Glands, 25, pp. 350-368. , G. L. Ellis, P. L. Auclair, and D. R. Gnepp (eds.), Philadelphia: W. B. Saunders Company